1. Home
  2. AIMD vs PRPO Comparison

AIMD vs PRPO Comparison

Compare AIMD & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • PRPO
  • Stock Information
  • Founded
  • AIMD 1984
  • PRPO N/A
  • Country
  • AIMD United States
  • PRPO United States
  • Employees
  • AIMD N/A
  • PRPO N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • AIMD Health Care
  • PRPO Industrials
  • Exchange
  • AIMD Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • AIMD 11.9M
  • PRPO N/A
  • IPO Year
  • AIMD N/A
  • PRPO N/A
  • Fundamental
  • Price
  • AIMD $3.11
  • PRPO $16.27
  • Analyst Decision
  • AIMD
  • PRPO
  • Analyst Count
  • AIMD 0
  • PRPO 0
  • Target Price
  • AIMD N/A
  • PRPO N/A
  • AVG Volume (30 Days)
  • AIMD 75.7K
  • PRPO 13.9K
  • Earning Date
  • AIMD 08-04-2025
  • PRPO 08-12-2025
  • Dividend Yield
  • AIMD N/A
  • PRPO N/A
  • EPS Growth
  • AIMD N/A
  • PRPO N/A
  • EPS
  • AIMD N/A
  • PRPO N/A
  • Revenue
  • AIMD $106,207.00
  • PRPO $20,029,000.00
  • Revenue This Year
  • AIMD N/A
  • PRPO N/A
  • Revenue Next Year
  • AIMD N/A
  • PRPO N/A
  • P/E Ratio
  • AIMD N/A
  • PRPO N/A
  • Revenue Growth
  • AIMD 13.38
  • PRPO 26.67
  • 52 Week Low
  • AIMD $2.00
  • PRPO $3.90
  • 52 Week High
  • AIMD $5.00
  • PRPO $16.50
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 57.16
  • PRPO 82.13
  • Support Level
  • AIMD $3.07
  • PRPO $10.60
  • Resistance Level
  • AIMD $3.34
  • PRPO $11.70
  • Average True Range (ATR)
  • AIMD 0.24
  • PRPO 0.86
  • MACD
  • AIMD 0.07
  • PRPO 0.43
  • Stochastic Oscillator
  • AIMD 79.73
  • PRPO 93.06

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: